Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Imprint / Legal Disclaimer

Address:

Merck KGaA
Frankfurter Strasse 250
64293 Darmstadt
Germany
Phone: +49 6151 72-0
Telefax: +49 6151 72-2000
Legal form: Corporation with general partners
Commercial Register: AG Darmstadt HRB 6164
Registered Office: Darmstadt
Chairman of the Supervisory Board: Dr. Wolfgang Büchele

Executive Board:

Dr. Stefan Oschmann (Chairman & CEO) 
Mr. Udit Batra, Ph.D. (CEO Life Science) 
Dr. Kai Beckmann (Chief Administration Officer) 
Mr. Walter Galinat (CEO Performance Materials)  
Ms. Belén Garijo, MD (CEO Healthcare) 
Dr. Karl-Ludwig Kley    
Dr. Marcus Kuhnert (CFO)
Value Added Tax Identification Number (VAT ID): DE 811850788
Competent Governmental Authority: Regierungspräsidium Darmstadt (Germany)

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in healthcare, “MilliporeSigma” in life science and “EMD Performance Materials.” The other company is Merck & Co., which uses the trademark MERCK only in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.  To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone. Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.
 

CONTACT:

Corporate Communications
Frankfurter Str. 250
64293 Darmstadt
Germany
Tel.: +49 6151 72-0
Fax: +49 6151 72-5577
 
 
  
Read more on M - The Explorer Magazine

“How are you girls doing today?”

Wound care with maggots is an old standard — especially in chronic cases. The basic requirements for maggot therapy include our special culture media that are needed to breed the larvae.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

The future is female!

One of the most important goals of the international community over the next few decades will be to improve women’s health and well- being. We funded a scientific study that examined the challenges.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

We're up all night creating the future!

Six challenges, eleven teams: At our hacker marathon (“hackathon”) in Tel Aviv, the participants competed to come up with the best practical solutions.

Read more on M - The Explorer Magazine